Researchers at Tel Aviv University have been able to develop a nanoparticle that can be used as a vaccine against fatal skin cancer melanoma.
The vaccine, published in the journal Nature Nanotechnology, was tested and tested on laboratory mice. The experiment has been shown to be most effective in three main situations: as a preventive treatment, as a remedy for primary tumor and metastatic eradication.